These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29365142)

  • 1. Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice.
    van Lieshout LP; Soule G; Sorensen D; Frost KL; He S; Tierney K; Safronetz D; Booth SA; Kobinger GP; Qiu X; Wootton SK
    J Infect Dis; 2018 Mar; 217(6):916-925. PubMed ID: 29365142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
    Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
    J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.
    Aviles J; Bello A; Wong G; Fausther-Bovendo H; Qiu X; Kobinger G
    J Infect Dis; 2015 Oct; 212 Suppl 2():S389-97. PubMed ID: 26038398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Transfer of ZMapp Antibodies Mediated by Recombinant Adeno-Associated Virus Protects Against Ebola Infections.
    Robert MA; Nassoury N; Chahal PS; Venne MH; Racine T; Qiu X; Kobinger G; Kamen A; Gilbert R; Gaillet B
    Hum Gene Ther; 2018 Apr; 29(4):452-466. PubMed ID: 29179602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challenge.
    van Lieshout LP; Rghei AD; Cao W; He S; Soule G; Zhu W; Thomas SP; Sorensen D; Frost K; Tierney K; Thompson B; Booth S; Safronetz D; Kulkarni RR; Bridle BW; Qiu X; Banadyga L; Wootton SK
    Mol Ther Methods Clin Dev; 2022 Sep; 26():505-518. PubMed ID: 36092367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model.
    Duehr J; Wohlbold TJ; Oestereich L; Chromikova V; Amanat F; Rajendran M; Gomez-Medina S; Mena I; tenOever BR; García-Sastre A; Basler CF; Munoz-Fontela C; Krammer F
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitopes involved in antibody-mediated protection from Ebola virus.
    Wilson JA; Hevey M; Bakken R; Guest S; Bray M; Schmaljohn AL; Hart MK
    Science; 2000 Mar; 287(5458):1664-6. PubMed ID: 10698744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of neutralizing antibodies against Ebola virus infection.
    Takada A; Ebihara H; Jones S; Feldmann H; Kawaoka Y
    Vaccine; 2007 Jan; 25(6):993-9. PubMed ID: 17055127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.
    Gupta M; Mahanty S; Bray M; Ahmed R; Rollin PE
    J Virol; 2001 May; 75(10):4649-54. PubMed ID: 11312335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 12. A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.
    Gunn BM; Yu WH; Karim MM; Brannan JM; Herbert AS; Wec AZ; Halfmann PJ; Fusco ML; Schendel SL; Gangavarapu K; Krause T; Qiu X; He S; Das J; Suscovich TJ; Lai J; Chandran K; Zeitlin L; Crowe JE; Lauffenburger D; Kawaoka Y; Kobinger GP; Andersen KG; Dye JM; Saphire EO; Alter G
    Cell Host Microbe; 2018 Aug; 24(2):221-233.e5. PubMed ID: 30092199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus.
    Audet J; Wong G; Wang H; Lu G; Gao GF; Kobinger G; Qiu X
    Sci Rep; 2014 Nov; 4():6881. PubMed ID: 25375093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection.
    Qiu X; Fernando L; Melito PL; Audet J; Feldmann H; Kobinger G; Alimonti JB; Jones SM
    PLoS Negl Trop Dis; 2012; 6(3):e1575. PubMed ID: 22448295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.
    Corti D; Misasi J; Mulangu S; Stanley DA; Kanekiyo M; Wollen S; Ploquin A; Doria-Rose NA; Staupe RP; Bailey M; Shi W; Choe M; Marcus H; Thompson EA; Cagigi A; Silacci C; Fernandez-Rodriguez B; Perez L; Sallusto F; Vanzetta F; Agatic G; Cameroni E; Kisalu N; Gordon I; Ledgerwood JE; Mascola JR; Graham BS; Muyembe-Tamfun JJ; Trefry JC; Lanzavecchia A; Sullivan NJ
    Science; 2016 Mar; 351(6279):1339-42. PubMed ID: 26917593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emergence of antibody therapies for Ebola.
    Hiatt A; Pauly M; Whaley K; Qiu X; Kobinger G; Zeitlin L
    Hum Antibodies; 2015 Dec; 23(3-4):49-56. PubMed ID: 27472862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model.
    Patel A; Park DH; Davis CW; Smith TRF; Leung A; Tierney K; Bryan A; Davidson E; Yu X; Racine T; Reed C; Gorman ME; Wise MC; Elliott STC; Esquivel R; Yan J; Chen J; Muthumani K; Doranz BJ; Saphire EO; Crowe JE; Broderick KE; Kobinger GP; He S; Qiu X; Kobasa D; Humeau L; Sardesai NY; Ahmed R; Weiner DB
    Cell Rep; 2018 Nov; 25(7):1982-1993.e4. PubMed ID: 30428362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of monoclonal antibodies for the treatment of Ebola virus disease.].
    Sizikova TE; Borisevich GV; Shcheblyakov DV; Burmistrova DA; Lebedev VN
    Vopr Virusol; 2018; 63(6):245-249. PubMed ID: 30641019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent neutralizing monoclonal antibodies against Ebola virus infection.
    Zhang Q; Gui M; Niu X; He S; Wang R; Feng Y; Kroeker A; Zuo Y; Wang H; Wang Y; Li J; Li C; Shi Y; Shi X; Gao GF; Xiang Y; Qiu X; Chen L; Zhang L
    Sci Rep; 2016 May; 6():25856. PubMed ID: 27181584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.
    Parren PW; Geisbert TW; Maruyama T; Jahrling PB; Burton DR
    J Virol; 2002 Jun; 76(12):6408-12. PubMed ID: 12021376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.